Home › Compound guides › Retatrutide

Compound guide

What Is Retatrutide?

One of the newest peptides in metabolic research — and the first "triple agonist." Here's what it is, how it works, and how it's handled, in plain English.

Retatrutide is one of the most talked-about peptides in current metabolic research. It belongs to the same broad family as semaglutide and tirzepatide — the GLP-1 receptor agonists — but it goes a step further, which is why it gets so much attention.

Research use only. This article is an educational overview of an investigational compound. It is not medical advice, makes no treatment or dosing recommendations, and does not describe human use. Retatrutide is not an approved medication.

What is retatrutide?

Retatrutide is a synthetic peptide — a chain of amino acids made in the lab. What sets it apart is that it's a triple agonist: a single molecule designed to activate three different receptors at once — the GLP-1, GIP, and glucagon receptors. It is investigational (still in clinical trials) and is supplied to researchers as a lyophilized powder for laboratory use.

How does it work?

"Agonist" just means a molecule that switches a receptor on. Each of retatrutide's three targets sits in a different part of the body's metabolic signalling system:

By engaging all three, retatrutide is studied as a way to act on multiple metabolic pathways with one compound — the reason it's often described as the next generation beyond single- and dual-receptor peptides.

Semaglutide hits one receptor, tirzepatide hits two, retatrutide hits three — that's the simplest way to place it.

Retatrutide vs tirzepatide vs semaglutide

The easiest way to understand where retatrutide fits is the progression in how many receptors each targets:

CompoundTypeReceptors
SemaglutideSingle agonistGLP-1
TirzepatideDual agonistGLP-1 + GIP
RetatrutideTriple agonistGLP-1 + GIP + glucagon

Each is its own compound with its own research profile — newer doesn't automatically mean "better," and they're studied for different reasons.

How is retatrutide handled in the lab?

Like most research peptides, retatrutide arrives as a lyophilized (freeze-dried) powder. Before it can be used in solution it has to be reconstituted:

Why purity matters

With an investigational peptide, knowing exactly what's in the vial is everything. A reputable source provides a Certificate of Analysis (COA) showing third-party HPLC purity and mass-spec identity for that specific batch. If you're not sure how to read one, see what is a COA.

Where to buy

Sourcing research-grade retatrutide

We recommend Vital Chems for tested compounds and bacteriostatic water.

  • Third-party HPLC tested — COA on every order
  • Same-day shipping before 1:30 PM PT
  • US-based, fast and responsive support
Visit Vital Chems →

Frequently asked questions

What is retatrutide?
An investigational synthetic peptide that acts as a triple agonist — it activates the GLP-1, GIP, and glucagon receptors. It's studied in metabolic research and supplied as a lyophilized powder for research use only.
How is it different from tirzepatide and semaglutide?
By how many receptors it targets: semaglutide is single (GLP-1), tirzepatide is dual (GLP-1 + GIP), retatrutide is triple (GLP-1 + GIP + glucagon).
How is it stored and prepared?
It ships as a freeze-dried powder, kept cool and dry, and is reconstituted with bacteriostatic water before use. After reconstitution it's refrigerated.
Is retatrutide approved?
No. It is investigational and still in clinical trials. It is sold and handled for research use only.
P

Peptide Starter Guide

Plain-English guides to handling research peptides correctly — reconstitution, dosing math, purity, and storage. Written for first-timers.